Dietmar Berger - 10 Mar 2026 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Signature
/s/ Amy Kim by Power of Attorney for Dietmar Berger
Issuer symbol
GILD
Transactions as of
10 Mar 2026
Net transactions value
$0
Form type
4
Filing time
12 Mar 2026, 16:22:25 UTC
Previous filing
02 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Berger Dietmar Chief Medical Officer 333 LAKESIDE DR., FOSTER CITY /s/ Amy Kim by Power of Attorney for Dietmar Berger 12 Mar 2026 0001739515

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +2,133 +12% 20,045 10 Mar 2026 Direct F1
transaction GILD Common Stock Tax liability -1,063 -5.3% $148.56* 18,982 10 Mar 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -2,133 -5.2% 39,046 10 Mar 2026 Common Stock 2,133 Direct F1, F2
transaction GILD Restricted Stock Unit Award +8,415 +22% 47,461 10 Mar 2026 Common Stock 8,415 Direct F1, F2
transaction GILD Non-qualified Stock Option (Right to Buy) Award +31,475 $0.000000* 31,475 10 Mar 2026 Common Stock 31,475 $148.56 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a 4-year vesting schedule. 25% vest on the first anniversary of the grant date. The balance will vest 6.25% quarterly thereafter until fully vested.
F3 The stock options have a four-year vesting schedule. 25% of the options vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.